Lifeline Biotechnologies Inc (LLBO)

[confirm]

Cyrcadia is a privately traded company, based in Reno, Nevada. Cyrcadia has achieved three patents through Lifeline Biotechnologies (LLBO), which is a publicly traded company that owns approximately 30% of Cyrcadia.
For further information, please contact Jim Holmes at [e-mail]
Our core science and the basis for our three patents is the discovery of the relationship between disruption of the body’s circadian body rhythms and tissue disruption. Prediction of the impact caused by Circadian rhythm disruption is the basis of the Circadian Health clinical trials. No one has developed a technology that competes with this core science. Many have validated our path of validation and discovery.

PPS—$.14 Price Per Share (updated from my 2018 PPS analysis & updated LLBO Cyrcadia Health percentage ownership!)...Ho Ho Ho off I go, good to see all my old friends again, even the ones that have been burned in the past apparently.